A combination of metformin and chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC) was not found to add survival benefit in the NRG Oncology clinical trial NRG-LU001 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results